Inquiry launched on Monday 4 February 2019. The closing date for written submissions was Monday 18 March 2019 (Parliament UK)
Bibliography: All Publications
Psychoactive substances
We collate information here about the reported effects of new psychoactive substances (NPS) and other drugs. Information comes from a range of intelligence sources (including RIDR) to support frontline practitioners, service providers and other stakeholders in responding to new and emerging health harms (Public Health England)
National intelligence network on drug health harms briefing: May 2019
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (Public Health England)
Allowing Pharmacists to Directly Dispense Opioid Antidote Can Sharply Cut Opioid Overdose Deaths
Allowing pharmacists to dispense the opioid antidote naloxone without a physician’s prescription can sharply reduce the incidence of fatal opioid-related overdoses, according to a new RAND Corporation study
Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm (Public Health England)
Changes in Stimulant Use and Related Harms: Focus on Methamphetamine and Cocaine
In response to recent reports of increasing harms related to methamphetamine use in Canada, this bulletin summarizes recent changes in stimulant-related harms in Canadian communities (CCSA)
Denying Revenue or Wasting Money?
Assessing the Impact of the Air Campaign Against ‘Drugs Labs’ in Afghanistan (LSE)
Alcohol and other drug treatment services in Australia 2017–18: key findings
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years (AIHW)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017. The number of treated cases increased from 8,361 in 2011 to 9,892 in 2015, and then decreased to 8,922 in 2017
An analysis of post-mortem toxicology practices in drug-related death cases in Europe
The objective of this report is to provide an updated analysis of the post-mortem toxicology practices of drug-related deaths (DRD) in Europe and to discuss the effect of these practices on the monitoring of DRDs (EMCDDA)
Cannabis policy and legislation in the Nordic countries
The Nordic Welfare Centre´s new report Cannabis policy and legislation in the Nordic countries looks at the similarities and differences in legislation and the ways in which the law is enacted in legal practice, police work, and other arenas
The Criminal Justice System and More Lenient Drug Policy
Three Case Studies on California’s Changes to How Its Criminal Justice System Addresses Drug Use (RAND)
Death penalty in 2018: Facts and figures
Amnesty International recorded at least 690 executions in 20 countries in 2018, a decrease of 31% compared to 2017 (at least 993). This figure represents the lowest number of executions that Amnesty International has recorded in the past decade
Prison Drugs Strategy (PDF)
This strategy has been developed by the Ministry of Justice (MoJ) and Her Majesty’s Prison and Probation Service (HMPPS), working with other partners across government. It sets out our plans to reduce the misuse of drugs in our prisons, and will provide direction to assist all stakeholders in this
Psychotropic Substances – Technical Report
On an annual basis the Psychotropics Control Section of the INCB Secretariat publishes a technical report that provides an overview of the world wide licit manufacture, export, import, stocks and consumption of substances controlled under the Convention on Psychotropic Substances of 1971 (INCB)
National Prison Drugs Strategy
Ministry of Justice and Her Majesty’s Prison and Probation Service Prison Drugs Strategy
National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018
On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)
The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Scottish Crime and Justice Survey 2017/18: Main Findings (PDF)
This summary presents a range of key findings from the 2017/18 Scottish Crime and Justice Survey (Scottish Government)
Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971
This circular draws attention to the contents of the below Statutory Instruments (SIs), S.I. 2018/1356 and 2018/1383, which will come into force at 00.01 on 1 April 2019 (Home Office)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 69
- Next Page »
